LIVE with J. Randolph Hecht, MD!

“Luncheon With The Experts” is a recurring educational outreach series (previously hosted by the Carcinoid Cancer Foundation) aimed at patients, caregivers, and the broader neuroendocrine cancer community. The sessions are hosted by Rain Bennett. The series features medical specialists — oncologists, surgeons, researchers, and other clinical experts — who specialize in topics relevant to neuroendocrine cancer and answer audience questions live via chat. Programs are typically delivered live (over Facebook Live and YouTube Live) at noon Eastern Time, allowing participants to join during their lunch break. Live sessions are recorded and will be available afterward. _________________________________________________________________________________________ ABOUT J. RANDOLPH (RANDY) HECHT, MD Gastrointestinal Medical Oncologist UCLA Health J. Randolph (Randy) Hecht, MD is a Professor of Clinical Medicine in the David Geffen School of Medicine at UCLA School of Medicine. He holds the Carol and Saul Rosenzweig Chair for Cancer Therapies Development and is the Director of the UCLA Gastrointestinal Oncology Program. He graduated from Eastern Virginia Medical School and took his internal medicine residency at Northwestern and completed fellowships in gastroenterology research at the University of Chicago, and in gastroenterology and medical oncology at UCLA. He is the director of the UCLA GI Oncology Program which has one of the largest clinical and research programs in the Western United States. Dr. Hecht is an internationally known clinical and translational researcher who has published widely in the field of gastrointestinal cancers. He has run multiple phase II and phase III trials with targeted therapies and immunotherapy. Dr. Hecht is currently leading national and international multicenter trials with novel immune and CAR-T therapies. Dr. Hecht has a longstanding interest in caring for neuroendocrine tumor patients and runs the multidisciplinary GI NET Clinical Conference. Dr. Randy Hecht is the Medical Director of the University of California Los Angeles (UCLA) GI Neuroendocrine Tumor Program. UCLA is one of the largest major centers for the treatment of neuroendocrine tumors in the western US. He has been the institutional principal investigator for multiple trials in neuroendocrine tumors including studies with novel somatostatin analogues, small molecules, DLL3 directed therapies and immunotherapies as well as the UC Pancreatic Neuroendocrine Neoplasm observational trial. Dr. Hecht works closely with his colleagues in nuclear medicine and has been the medical principal investigator for nuclear medicine trials with lutetium-177 and actinium-225 based therapies. He is also on the medical advisory council of the Neuroendocrine Cancer Foundation, one of the largest NET patient advocacy groups in the world, and serves on the Steering Committee for the development of the NANETS clinical practice guidelines on “Systemic Therapies for Midgut Neuroendocrine Tumors.” _________________________________________________________________________________________ Go to https://www.ncf.net/lwte/aug2026 for more information.